Pharmalot... Pharmalittle... Good Morning

Good morning, everyone, and nice to see you again. Was the weekend relaxing and invigorating? We certainly enjoyed the respite. Now, though, the time has come to resume the routine of meetings and deadlines. And there are many of those this week. In fact, we are hosting a webinar this Wednesday on the Sunshine Act and invite you to join us (please see this). Meanwhile, here are some tidbits to get you started on the day. Hope all goes well and stay in touch...

Buffet May Sell Johnson & Johnson Stock (Reuters)

Glenmark Recalls Birth Control Pills (WebMD)

FDA Rejects Premature Birth Gel From Watson And Columbia (Reuters)

Pediatricians Back Gardasil For Boys 11 And Older (Reuters)

Glaxo Recalls Drug Made At Troubled Novartis Plant (Reuters)

Roche Extends Hostile Bid For Illumina (Bloomberg News)

Five Reasons Chelsea Therapeutics Drug Will Get Approved (The Street)

Takeda Diabetes Drug Fights Diabetes As Well As Older Generic (Bloomberg News)

Ireland And Drugmakers At An Impasse Over Prices (Irish Times)

Lilly To Expand Irish Facility And Add 200 Jobs (Irish Examiner)

Indian Drugmakers Upset That Agency Named Temporary Head (Economic Times)

EDITOR’S NOTE: Please check this post for updates throughout the morning

sunrise pic thx to benimoto on flickr